By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

The fight against obstructive sleep apnea (OSA) has taken a monumental leap forward. For the first time, the U.S. Food and ...

The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep ...

The FDA on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and ...

"Today's approval marks the first drug treatment option for certain patients with obstructive sleep apnea," said Sally ...

A custom, fitted mouthguard may be effective at managing sleep apnea or reducing its severity ... may be more effective for people who: These side effects may resolve with regular use of the ...

The obesity medication Zepbound can be used on-label to treat obstructive sleep apnea in adults with obesity, the FDA ...

Researchers have categorized sleep ... are causing side effects that interfere with sleep Sleep evaluations, which can diagnose conditions like restless legs syndrome or sleep apnea.

The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...

FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in ...

Zepbound is Eli Lilly’s weight loss drug. Now, it is also a drug to treat obstructive sleep apnea (OSA).The U.S. Food and ...

The Food and Drug Administration has approved Zepbound to treat obstructive sleep apnea for people who are moderately or ...